TG Therapeutics
TGTX
TGTX
179 hedge funds and large institutions have $964M invested in TG Therapeutics in 2022 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 73 increasing their positions, 47 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
28% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 43
49% less capital invested
Capital invested by funds: $1.91B → $964M (-$942M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
179
Holding in Top 10
1
Calls
$28M
Puts
$22.1M
Top Buyers
| 1 | +$36.2M | |
| 2 | +$15.6M | |
| 3 | +$13.2M | |
| 4 |
AC
Antara Capital
New York
|
+$9.84M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$9.83M |
Top Sellers
| 1 | -$79.3M | |
| 2 | -$42M | |
| 3 | -$22M | |
| 4 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$18.3M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$12.6M |